Clinical Trial: Cabozantinib for Malignant Pheochromocytoma

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Pilot Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable Metastatic Pheochromocytomas and Paragangliomas

Brief Summary: The goal of this clinical research study is to learn if cabozantinib can help to control advanced or metastatic pheochromocytoma or paraganglioma. The safety of this drug will also be studied.